Metabolite | HMDB ID | Calrose | Dixiebelle | Neptune | Function | References |
---|---|---|---|---|---|---|
4-guanidinobutanoate (Rhapontigenin)a | 03464 | 99.84 | 194.48 | 153.27 | • Anti-hyperlipidemic • Antifungal (Candida albicans in vitro) • Antioxidant (protection against cellular DNA damage caused by intracellular reactive oxygen species (ROS)) | (Jo et al. 2014) (Zhang et al. 2007) |
4-hydroxycinnamic acid | 02035 | 3.61 | 6.62 | 9.49 | • Antioxidant (protective against oxidative damage caused by ROS) | (Shang et al. 2015) |
5-oxoproline (Pyroglutamic acid) | 00267 | 10.80 | 22.81 | 41.36 | • Increases the release of acetylcholine (Ach) and GABA from the cortical surface to improve the age associated memory impairment | (Antonelli et al. 1984) (Grioli et al. 1990) |
3-(4-hydroxyphenyl) lactate | 00755 | 0.35 | 0.57 | 1.09 | • Antioxidant (decrease the ROS production in neutrophils and mitochondria) • Antifungal (against main genera: Penicillum, Aspergillus and Fusarium) | (Beloborodova et al. 2012) (Dallagnol et al. 2011) |
α-hydroxyisocaproic acid (Leucic acid)a | 00746 | 0.16 | 0.21 | 0.45 | • Antifungal (against Candida and Aspergillus species) • Antibacterial (broad spectrum bacteriostatic properties) • Anti-catabolic (inhibitory effect on various matrix metalloproteinase enzymes, which are responsible for degradation of various connective and protein tissues → muscle gaining) | (Sakko et al. 2014) (Sakko et al. 2012) (Mero et al. 2010) |
Agmatinea | 01432 | 6.89 | 0.95 | 5.23 | • Anti-nociceptive (without affecting morphine-induced gastrointestinal transit) • Anti-hypertensive • Cancer chemopreventive • Renal sodium regulation • Antihyperglycemic (increases insulin release from rat pancreatic islets of Langerhans cells) | (Raasch et al. 2001) (Piletz et al. 2013) |
Betaine | 00043 | 249.03 | 197.66 | 308.76 | • Protects against atherosclerosis (helps reduce higher levels of homocysteine) • Prevents hepatic steatosis, prevents cirrhosis (prevents or reduces accumulation of fat in the liver) • Protects against genetic instability, senescence, and cancer through DNA methylation | (Craig, 2004) |
Citrulline | 00904 | 2.72 | 0.34 | ND | • Anti-hypertensive (increases the arginine availability as its precursor and arginine sustains increase in nitrogen oxide (NO) production) • Anti-hyperlipidemic | (Kaore et al. 2013) |
Cystathionine | 00099 | ND | 0.75 | 1.05 | • Anti-inflammatory | (Zhu et al. 2015) |
Carboxyethyl-GABA | 02201 | 11.50 | 12.42 | 16.56 | • Immune modulator | (Cerino et al. 1988) |
GABA (Gamma-aminobutyric acid) | 00112 | 163.45 | 121.42 | 102.60 | • Inhibitory neurotransmitter → Relaxant, anxiolytic and anti-convulsive (antiepileptic) | (Foster and Kemp, 2006) (Chapouthier and Venault, 2001) |
Gentisatea | 00152 | ND | 0.07 | 0.27 | • Anti-inflammatory (via free radical scavenging) • Antirheumatic | (Carlin et al. 1985) |
Glutamate | 00148 | 777.00 | 581.99 | 571.80 | • Required for central nervous system function and treating neuropsychological conditions • Immunomodulator (development of T-cell-mediated immunity by stimulating glutamate-specific receptors) | (Hettema et al. 2006) (Pacheco et al. 2007) (Pietersen et al. 1998) |
Glutathione, reduced (GSH) | 00125 | 25.76 | 21.87 | 14.02 | • Antioxidant (as a nucleophile and a reductant, and can react with electrophilic or oxidizing species | (Pompella et al. 2003) |
Hydrocinnamic acid | 00764 | 0.07 | 0.09 | ND | • Anti-inflammatory (control of the degranulation of mast cells, basophils and neutrophils) | (Panico et al. 2005) |
Indoleacetatea | 00197 | 1.85 | 1.73 | 0.98 | • Cancer chemopreventive | (Folkes and Wardman, 2001) |
N-Acetyl histidine (NAH) | 32055 | 8.65 | 11.33 | 3.36 | • Anti-cataract formation (it is one the two major constituents of the vertebrate brain and eye) | |
Serotonin | 00259 | 4.71 | 2.50 | 14.11 | • Neurotransmitter • Antiemetic | (Peroutka et al. 1981) (De-Miguel and Trueta, 2005) |
N-Acetylserotonin | 01238 | ND | 0.09 | 0.41 | • Anti-insomnia (this is the immediate precursor of melatonin) • antidepressant & anxiolytic • Anti-hypertensive • Antioxidant (lowers resting levels of ROS in peripheral blood lymphocytes, and inhibits nitric oxide synthase) • Anti-inflammatory | (Touitou, 2001) (Oxenkrug, 1999; Oxenkrug et al. 2007) (Reiter et al. 1999) (Perianayagam et al. 2005) |
N-acetylleucinea | 11756 | 0.12 | 0.17 | 0.41 | • Vertigo treatment | |
N-Acetyl-L-tyrosine | 00866 | 0.10 | 0.20 | 0.44 | • Treatment of neurotransmitter dysfunction (administration of this amino acid acts as a precursor of catecholamine, dopamine and serotonin) | |
N-acetyltryptophan | 13713 | ND | 0.19 | 0.55 | • Antioxidant (diminishes oxidation of human serum albumin) • Neuro-protective (Treatment of neurodegenerative disease such as amyotrophic lateral sclerosis) | (Anraku et al. 2004) (W. Li et al. 2015) |
N-methyltyrosine (Metyrosine) | 14903 | 0.06 | ND | ND | • Anti-hypertensive (inhibits tyrosine hydroxylase) | |
Norvaline | 13716 | 0.13 | ND | 0.07 | • Anti-inflammatory (via inhibition of ribosomal protein S6 kinase beta-1 (S6K1)) • Improves sperm motility, count and viability in diabetic rats (inhibits the arginase enzyme and increases arginine availability as substrate to interact with endothelial nitric oxide synthase (eNOS)) | (Ming et al. 2009) (De et al. 2016) |
Ornithine | 03374 | 1.42 | 0.12 | 0.27 | • Antifatigue (increases release of human growth hormone by stimulating pituitary gland) | (Sugino et al. 2008) |
Phenyllactic acida | 00779 | 0.28 | 0.37 | 0.59 | • Antifungal (against Fusarium graminearum IDM623, Endomyces fibuliger IDM3812, Penicillium expansum IDM/FS2, Aspergillus niger IDM1, and Monilia sitophila IDM/FS5) • Antibacterial (against Klebsiella oxytoca (g-), Providencia stuartii (g-), Enterococcus faecalis (g+), Staphylococcus aureu (g+) and Listeria monocytogenes (g+)) | (Lavermicocca et al. 2000) (Dieuleveux et al. 1998) |
Picolinic acid | 02243 | 0.22 | 0.66 | 0.19 | • Increases the bioavailability of elements such as zinc, iron, copper, manganese and molybdenum in the human body • Anti-inflammatory | (Grant et al. 2009) (Bosco et al. 2000) |
Taurinea | 00251 | 1.41 | 1.92 | 1.92 | • Antioxidant (found in large quantities in the neutrophil and excitable tissues, is a powerful scavenger of hypochlorous acid) • Lowers lead and cadmium levels in blood and tissues • Obesity prevention (increases energy metabolism in white adipose tissue) • Anti-hypertensive • Neuroprotective against glutamate excitotoxicity • Anti-hyperlipidemic | (Christophersen, 2012) (Gurer et al. 2001) (Sinha et al. 2008) (Tsuboyama-Kasaoka et al. 2006) (Leon et al. 2009) (El Idrissi et al. 2003) (Yanagita et al. 2008) (Huxtable, 1992) |
Trans-urocanate (t-Urocanic acid) | 00301 | 0.58 | 0.77 | 2.24 | • Ultraviolet (UV) protectant (natural sunscreen) | (Egawa et al. 2010) |